Tunnell’s subject matter experts have written a number of informative pieces. Here are a sampling of articles that have been published in leading industry publications.
VIEW OUR PUBLISHED ARTICLES BELOW
Nov. 2017 – Tunnell Managing Consultant, Kip Wolf, discusses the challenges to M&A integration and “maintaining business continuity, transferring appropriate knowledge, and transferring information assets in a timely and effective manner.”
June, 2017 – “Minimum viable product” may work well for software, but pharma needs to get it right the first time, and develop a culture of quality, tied to metrics, and encouraging change where the work actually takes place. This article in Innovation Excellence quotes Tunnell’s Al Riles and Bob Johnson on defining the four components of a quality culture.
April, 2016 – The key to successful technology transfer and facility startup is in strong project management, and it may make all the difference between a successful launch and one plagued by delays. Careful planning can help avoid the pitfalls often found in transferring processes between facilities. This article in BioPharm International, by Tunnell’s Walter Matzmorr, discusses the complexities inherent in technology transfer, and details how to successfully shorten time-to-market and avoid costly mistakes.
August, 2015 – Biopharma needs to combine a “culture of quality” with value-added process improvements in manufacturing. Here are key steps and strategies that can make a difference–and deliver bottom-line results.
November, 2012 – Understanding overall supplier capability versus the critical-to-quality attributes of your product can reduce both risk and cost.
March, 2011 – New supply chain challenges, including counterfeits, are forcing companies to act in different ways to secure produce safety.
Feb, 2011 – Poor planning and misguided implementation when conducting technology transfer can lead to problems with budget, scheduling, compliance and supply.